Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin
- PMID: 177271
- DOI: 10.1210/endo-98-3-722
Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin
Abstract
The "ovarian-dependent" rat mammary tumors, induced by 9,10 dimethyl-1,2-benzanthracene, were assayed for their estrogen receptor content by dextran-coated charcoal adsorption and sucrose gradient ultra-centrifugation. The estradiol receptors bound estrogens with a high affinity (KD approximately 0.25 nM), limited capacity and high specificity, and sediment at 8 S in a sucrose gradient. The cytosol receptors were transferred to the nucleus after binding to estrogens either in vivo or in vitro. The tumor area regressed by 70% during the first 10 days of castration while the concentration of estradiol cytosol receptors decreased from 225 to 16 fmoles/mg of protein. Three to five days after in vivo administration of estradiol (2 mug daily) or prolactin (1 mg daily) the concentration of estrogen receptors was increased in spayed rats. In biopsy experiments, prolactin, but not estradiol, was shown to increase the estrogen receptor concentration when endogenous prolactin release was blocked by CB 154. Prolactin did not modify the intracellular distribution of the estrogen receptor or its binding affinity for estrogen. The uterine estrogen receptor sites were not modified by prolactin under the same conditions. We, therefore, suggest that in mammary tumors prolactin sensitizes the action of estrogens at the target level by increasing the concentration of their available receptor sites.
Similar articles
-
[Regulation of estrogen "receptors" in mammary tumors: action of prolactin in vivo].C R Acad Hebd Seances Acad Sci D. 1974 Jan;278(1):103-6. C R Acad Hebd Seances Acad Sci D. 1974. PMID: 4368243 French.
-
High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.Cancer Res. 1977 Jan;37(1):76-81. Cancer Res. 1977. PMID: 187338
-
Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.Cancer Res. 1976 Feb;36(2 Pt 1):354-8. Cancer Res. 1976. PMID: 177195
-
[Estrogen receptors in human and animal mammary gland tumors].Vopr Onkol. 1975;21(5):118-26. Vopr Onkol. 1975. PMID: 174310 Review. Russian. No abstract available.
-
Relation of the neuroendocrine system to the development and growth of experimental mammary tumors.J Neural Transm. 1980;48(1):25-42. doi: 10.1007/BF01670031. J Neural Transm. 1980. PMID: 6106045 Review.
Cited by
-
Role of steroid hormones and morphine treatment in the modulation of opioid receptor gene expression in brain structures in the female rat.Springerplus. 2015 Jul 16;4:355. doi: 10.1186/s40064-015-1021-8. eCollection 2015. Springerplus. 2015. PMID: 26191482 Free PMC article.
-
Presurgical radiotherapy decreases the concentrations of estrogen and progesterone receptors in human breast cancer: a 200-patient study.Breast Cancer Res Treat. 1982;2(2):177-83. doi: 10.1007/BF01806454. Breast Cancer Res Treat. 1982. PMID: 7171838 No abstract available.
-
Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.Cancer Chemother Pharmacol. 1991;27(4):271-7. doi: 10.1007/BF00685111. Cancer Chemother Pharmacol. 1991. PMID: 1825621
-
Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?Br J Cancer. 1990 Jun;61(6):877-80. doi: 10.1038/bjc.1990.196. Br J Cancer. 1990. PMID: 2372489 Free PMC article.
-
Treatment of benign breast disease with bromocriptine.J Endocrinol Invest. 1979 Jan-Mar;2(1):87-91. doi: 10.1007/BF03349282. J Endocrinol Invest. 1979. PMID: 489922
MeSH terms
Substances
LinkOut - more resources
Full Text Sources